Studies have shown that active fund managers routinely underperform the S&P500 index*​

Forte Biosciences, Inc. (NASDAQ: FBRX)

FBRX Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
297.10%

FBRX Stock Analysis

FBRX PE Ratio:

FBRX PEG Ratio: Not Available

FBRX Forward EPS Growth (12 month): 0.00%

FBRX PS Ratio:

FBRX PSG Ratio: Not Available

FBRX Forward Revenue Growth (12 month): 0.00%

FBRX Articles

No data was found